Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Varas-Lorenzo, C.  [Clear All Filters]
Journal Article
C. Varas-Lorenzo, Garcia-Rodriguez, L. A., Perez-Gutthann, S., and Duque-Oliart, A., Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study, Circulation, vol. 101, pp. 2572-8, 2000.
C. Varas-Lorenzo, Arana, A., Johannes, C. B., McQuay, L. J., Rothman, K. J., and Fife, D., Improving the Identification of Out-of-Hospital Sudden Cardiac Deaths in a General Practice Research Database, Drugs Real World Outcomes, vol. 3, pp. 353-358, 2016.
S. Perez-Gutthann, Garcia-Rodriguez, L. A., Duque-Oliart, A., and Varas-Lorenzo, C., Low-dose diclofenac, naproxen, and ibuprofen cohort study, Pharmacotherapy, vol. 19, pp. 854-9, 1999.
M. Cainzos-Achirica, Varas-Lorenzo, C., Pottegard, A., Asmar, J., Plana, E., Rasmussen, L., Bizouard, G., Forns, J., Hellfritzsch, M., Zint, K., Perez-Gutthann, S., and Pladevall-Vila, M., Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe, Pharmacoepidemiol Drug Saf, vol. 27, pp. 713-723, 2018.
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population, Heart, vol. 92, pp. 1610-5, 2006.
A. Arana, Johannes, C. B., McQuay, L. J., Varas-Lorenzo, C., Fife, D., and Rothman, K. J., Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study, Drug Saf, vol. 38, pp. 1187-99, 2015.
A. Arana, Margulis, A. V., Varas-Lorenzo, C., Bui, C. L., Gilsenan, A., McQuay, L. J., Reynolds, M., Rebordosa, C., Franks, B., de Vogel, S., Appenteng, K., and Perez-Gutthann, S., Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom, Pharmacoepidemiol Drug Saf, 2020.
A. Arana, Margulis, A. V., McQuay, L. J., Ziemiecki, R., Bartsch, J. L., Rothman, K. J., Franks, B., D'Silva, M., Appenteng, K., Varas-Lorenzo, C., and Perez-Gutthann, S., Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study, Pharmacotherapy, vol. 38, pp. 628-637, 2018.
[Page last reviewed 4 March 2021]